The first message to mankind at the dawn of the 21st century was the completion of gene map of the human genome.
The Human Genome Project, an attempt to discover entire human genomic structure has allowed us new approaches to biological phenomena, along with the fact that the secret about life is informationized. These accomplishments that the human has achieved contribute to a new paradigm, information medicine which means that the era of customized individual medicine and remote medical service has already begun, based on human genome information and bioinformatics.

In order to complete the medical revolution of 21st century characterized by regenerative and informatic medicine, supporting tools are indispensable. In the light of this, Macrogen Inc. have developed and commercialized basic tools for the genome medicine from genetic information analysis up to functional genomics by using bioinformatics infrastructure. Moreover, with continuous R&D on genomics, Macrogen Inc. have been able to broaden the range of genomics industry by inventing ‘Super Alcohol Bacteria’ and a congenital-hereditary-disease diagnosing kit. Furthermore, Macrogen Inc. not only commercialized genetically engineered mice production as well as cloning technology, but also have challenged xenotransplant industry by establishing MGenbio Inc.

“Sharply but Sincerely”
All staff of Macrogen Inc. are being encouraged by the infinite vision of bio industry and feel great responsibilities as one of leading companies in bio industry.
Based on steady R&D, boosting business efficiency, and clear corporate ethics, we, Macrogen Inc. will become a role model of biotech company which place it on the top priority to maximize the profit of shareholders and contribute to communities.

Thank you.